By Mike Montemarano, Associate Editor02.04.22
In late January, analysis from the VITAL study conducted by researchers at Harvard University found that taking 2,000 IU of vitamin D and 1 gram of omega-3 fatty acids daily for two years resulted in a 22% reduced risk of developing certain autoimmune diseases compared to taking a placebo. VITAL’s primary endpoints were tracking cardiovascular events, and involved 25,871 participants aged 55 and older and followed up with them for a median of 5.3 years.
Autoimmune diseases (ADs), in which the immune system mistakenly attacks cells in the body, include conditions such as celiac disease, rheumatoid arthritis, psoriasis, lupus, MS, type 1 diabetes, and many more, affecting an estimated 23.5 million Americans, according to NIH estimates.
When considering three years of post-intervention follow-up, the risks of developing an AD were reduced by 39% in the vitamin D arm of the study, and 10% among those who took omega-3s. Supplementation with both nutrients resulted in a 30% decrease in AD versu
Autoimmune diseases (ADs), in which the immune system mistakenly attacks cells in the body, include conditions such as celiac disease, rheumatoid arthritis, psoriasis, lupus, MS, type 1 diabetes, and many more, affecting an estimated 23.5 million Americans, according to NIH estimates.
When considering three years of post-intervention follow-up, the risks of developing an AD were reduced by 39% in the vitamin D arm of the study, and 10% among those who took omega-3s. Supplementation with both nutrients resulted in a 30% decrease in AD versu
Continue reading this story and get 24/7 access to Nutraceuticals World for FREE
FREE SUBSCRIPTION
